| Primary |
| Asthma |
51.9% |
| Product Used For Unknown Indication |
10.2% |
| Drug Use For Unknown Indication |
9.1% |
| Chronic Obstructive Pulmonary Disease |
5.9% |
| Nasopharyngitis |
4.3% |
| Immunosuppression |
3.2% |
| Prophylaxis |
3.2% |
| Diabetes Mellitus |
1.6% |
| Acne |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Emphysema |
1.1% |
| Hormone Replacement Therapy |
1.1% |
| Hypertension |
1.1% |
| Inhalation Therapy |
1.1% |
| Lung Disorder |
1.1% |
| Upper Respiratory Tract Infection |
1.1% |
| Angina Pectoris |
0.5% |
| Bipolar Disorder |
0.5% |
| Cardiac Failure |
0.5% |
| Chronic Sinusitis |
0.5% |
|
| Asthma |
8.7% |
| Urticaria |
8.7% |
| Cough |
6.5% |
| Oesophageal Candidiasis |
6.5% |
| Swelling |
6.5% |
| Chest Discomfort |
4.3% |
| Dyspnoea |
4.3% |
| Increased Tendency To Bruise |
4.3% |
| Insomnia |
4.3% |
| Lung Infection |
4.3% |
| Mesothelioma |
4.3% |
| Migraine |
4.3% |
| Muscle Spasms |
4.3% |
| Palpitations |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Tongue Oedema |
4.3% |
| Vision Blurred |
4.3% |
| Weight Increased |
4.3% |
| Wheezing |
4.3% |
| Anaphylactic Reaction |
2.2% |
|
| Secondary |
| Asthma |
25.2% |
| Chronic Obstructive Pulmonary Disease |
15.4% |
| Product Used For Unknown Indication |
14.4% |
| Drug Use For Unknown Indication |
5.9% |
| Prophylaxis |
5.4% |
| Emphysema |
4.4% |
| Hypertension |
2.9% |
| Osteoporosis |
2.7% |
| Diabetes Mellitus |
2.4% |
| Coronary Artery Disease |
2.2% |
| Nasopharyngitis |
2.2% |
| Sedation |
2.2% |
| Acute Lymphocytic Leukaemia |
2.0% |
| Oropharyngeal Pain |
2.0% |
| Pyrexia |
2.0% |
| Upper Respiratory Tract Inflammation |
2.0% |
| Atrial Fibrillation |
1.7% |
| Bronchitis |
1.7% |
| Cardiac Disorder |
1.7% |
| Cough |
1.7% |
|
| Mesothelioma |
18.3% |
| Urticaria |
8.5% |
| Asthma |
7.0% |
| Drug Ineffective |
7.0% |
| Oligohydramnios |
7.0% |
| Aortic Dissection |
4.2% |
| Cystitis Haemorrhagic |
4.2% |
| Diarrhoea |
4.2% |
| Nightmare |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Talipes |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Cerebrovascular Accident |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Dyspnoea |
2.8% |
| Dyspnoea Exertional |
2.8% |
| Emphysema |
2.8% |
| Eyelid Oedema |
2.8% |
| Gun Shot Wound |
2.8% |
| Headache |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
24.1% |
| Asthma |
14.7% |
| Hypertension |
6.4% |
| Hiv Infection |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Depression |
2.8% |
| Pain |
2.4% |
| Diabetes Mellitus |
1.6% |
| Hepatitis C |
1.5% |
| Prophylaxis |
1.5% |
| Constipation |
1.3% |
| Dyspepsia |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Schizophrenia |
1.2% |
| Osteoporosis |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Type 2 Diabetes Mellitus |
1.0% |
| Psoriasis |
1.0% |
|
| Vomiting |
10.5% |
| Pyrexia |
6.9% |
| Pneumonia |
6.4% |
| Myocardial Infarction |
5.9% |
| Nausea |
5.3% |
| Pain |
5.3% |
| Wheezing |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Death |
5.0% |
| Liver Function Test Abnormal |
5.0% |
| Myositis |
5.0% |
| Thrombocytopenia |
5.0% |
| Contusion |
4.1% |
| Rash |
4.1% |
| Urinary Tract Infection |
4.1% |
| Tendonitis |
3.9% |
| Suicidal Ideation |
3.4% |
| Dyspnoea |
3.2% |
| Neutropenia |
3.2% |
| Asthma |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Asthma |
25.0% |
|
|
